Angiotensin II receptor antagonists

Details for Australian Patent Application No. 2006240247 (hide)

Owner Merck & Co., Inc.

Inventors Dubost, David C.; Pourkavoos, Nazaneen; Ghosh, Soumojeet; Tatavarti, Aditya; Foster, Bruce S.; Alani, Laman L.; Rege, Bhagwant; Jahansouz, Hossain

Agent Spruson & Ferguson

Pub. Number AU-A-2006240247

PCT Pub. Number WO2006/115834

Priority 60/673,086 20.04.05 US

Filing date 14 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/115834 Priority application(s): WO2006/115834

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006240248-Benzothiophene hydroxamic acid derivatives

2006240246-Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions